A novel long-acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in deep vein thrombosis. A phase II evaluation - Büller, HR; Cohen, AT; Lensing, AWA (J Thromb Haemost, 2004)